Clinical trial

Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT

NCT03648814

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Intracameral injection Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Intravitreal injection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2018-08-01

PhaseNA

Conditions

Glaucoma, Neovascularunresolved

Vascular Endothelial Growth Factor Overexpressionunresolved

Interventions

Intracameral injectionPROCEDURE

Intravitreal injectionPROCEDURE

Sponsors & collaborators

Prince of Songkla Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03648814 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.